Skip to Content

Notice

Notice of Intent To Grant Exclusive Patent License; Bioforce Nanosciences, Inc.

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Department of the Navy, DoD.

ACTION:

Notice.

SUMMARY:

The Department of the Navy hereby gives notice of its intent to grant to Bioforce Nanosciences, Inc., a revocable, nonassignable, exclusive license to practice in the United States and certain foreign countries, the Government-owned inventions described in U.S. Patent No. 5,372,930 (Navy Case No. 73,568) issued December 13, 1994, entitled “Sensor for Ultra-Low Concentration Molecular Recognition” U.S. Patent No. 5,958,701 (Navy Case No. 79,257) issued September 28, 1999, entitled “Method for Measuring Intramolecular Forces by Atomic Force”; and U.S. Patent No. 5,992,226 (Navy Case No. 78,838) issued November 30, 1999, entitled “Apparatus and Method for Measuring Intermolecular Interactions by Atomic Force Microscopy”.

DATES:

Anyone wishing to object to the grant of this license must file written objections along with supporting evidence, if any, not later than July 17, 2002.

ADDRESSES:

Written objections are to be filed with the Naval Research Laboratory, Code 1004, 4555 Overlook Avenue, SW, Washington, DC 20375-5320.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Catherine M. Cotell, Ph.D. Head, Technology Transfer Office, NRL Code 1004, 4555 Overlook Avenue, SW, Washington, DC 20375-5320, telephone (202) 767-7230. Due to U.S. Postal delays, please fax (202) 404-7920, e-mail: cotell@nrl.navy.mil or use courier delivery to expedite response.

(Authority: 35 U.S.C. 207, 37 CFR part 404.)

Start Signature
Start Printed Page 44429

Dated: June 25, 2002.

R.E. Vincent, II,

Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy, Federal Register Liaison Officer.

End Signature End Further Info End Preamble

[FR Doc. 02-16587 Filed 7-1-02; 8:45 am]

BILLING CODE 3810-FF-P